Canaccord analyst Richard Close believes the weakness in shares of Health Insurance Innovations from news of an Energy and Commerce Committee's "investigation" provides a buying opportunity. Health Insurance Innovations has focused intently in recent years on improving the quality of plans offered on its platform and the compliance to best practices by which those products are sold, he notes, adding that the Trump Administration has made an effort to provide consumers greater options and choice for health insurance, and short-term medical insurance is an effective option. The analyst does not expect the Administration backing down from its position, and expects the rule changes to remain in place. Close reiterates a Buy rating and $62 price target on the shares.